Why Choose Mount Sinai

Being diagnosed with a blood disorder or cancer is life-changing and scary. It is important for you/your child to have confidence in the care provided by our medical team. We know that families will go to the ends of the Earth to get the best possible treatment. Fortunately, you don’t have to travel far. The Jack Martin Division of Pediatric Hematology and Oncology within the Mount Sinai Health System offers the latest, most comprehensive care available in both our inpatient and outpatient facilities right in the heart of New York City.

  • All our physicians are board-certified Pediatric Hematologists and Oncologists skilled in treating blood disorders and cancers specific to children, teenagers, and young adults.
  • Highly specialized care requires a collaborative approach between your child’s providers. We are proud to work closely with surgeons, radiation oncologists, pathologists, radiologists, and many more specialists who are trained in the discipline of Pediatrics. 
  • To achieve the best possible results, our team works with a combination of specialized nursing, pharmacy, rehabilitation, and paramedical personnel, and we have access to increasingly complex equipment and facilities.
  • Mount Sinai and the Kravis Children’s Hospital bring together state-of-the-art technology with child-friendly facilities and support services.

We are dedicated to providing family-centered care to all of our pediatric, adolescent, and young adult patients. Our doctors and staff take the time to get to your child and take an individualized approach to your child’s specific needs while maintaining the highest standards of care. Our goal is to cure your child’s cancer and to provide effective, life-sustaining treatment to help your child grow up strong and fulfill his or her dreams.

Mount Sinai Kravis Children’s Hospital’s Children’s Cancer Program gives your child access to an even larger and unprecedented scope of pediatric services including access to the newest treatments and expertise in pediatric oncology.

Our pathology department, working together with our genetic and genomics services, offers the newest molecular tests, including tumor sequencing. We assist in setting up these appointments and keep in regular contact with our families.

In addition, several of our doctors are actively involved with research efforts in bone marrow transplantation, cellular therapy, lymphoma, and Langerhans cell histiocytosis, among others. The Division of Pediatric Hematology-Oncology is a member of the Children’s Oncology Group, the Pediatric Blood and Marrow Transplant Consortium, and the North American Consortium of Histiocytic Disorders. These connections enable our patients to participate in clinical trials when appropriate.